Inventor · disambiguated record
Yann Dean
Also filed as: DEAN YANN
6 granted patents·7 pending applications·288 citations·filing 2005–2020
84Inventor score
Top patents by PatentIndex Score
13 records- 0198US7728114B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2005·Granted Jun 1, 2010·260 cites·25 claims
- 0288US8551478B2Anti-CD3 antibodies and methods of use thereofMACH BERNARD·Filed 2010·Granted Oct 8, 2013·14 cites·14 claims
- 0386US10494427B2Anti-netrin-1 antibodyNETRIS PHARMA·Filed 2015·Granted Dec 3, 2019·8 cites·14 claims
- 0485US9850304B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Dec 26, 2017·5 cites·3 claims
- 0581US10759858B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Sep 1, 2020·1 cites·14 claims
- 0671US2021009691A1Anti-cd3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2020·Application pending·0 cites
- 0760US11648309B2Anti-netrin-1 antibodyNETRIS PHARMA·Filed 2019·Granted May 16, 2023·0 cites·12 claims
- 0852US2007065437A1Anti-CD3 antibody formulationsELSON GREG·Filed 2006·Application pending·0 cites
- 0952US2010209437A1Anti-CD3 Antibody FromulationsELSON GREG·Filed 2006·Application pending·0 cites
- 1051US2020069797A1Combination therapies and methods using anti-cd3 modulating agents and anti-il-6 antagonistsNOVIMMUNE SA·Filed 2019·Application pending·0 cites
- 1146US2014199299A1Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 AntagonistsNOVLMMUNE S A·Filed 2014·Application pending·0 cites
- 1241US2012189621A1Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 AntagonistsDEAN YANN·Filed 2012·Application pending·0 cites
- 1337US2005265993A1Methods of treating autoimmune and inflammatory diseasesMACH BERNARD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yann Dean files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →